By modulating the expression of low-density lipoprotein receptor (LDL-R), PCSK9 is a key regulator of cholesterol metabolism [1,2] and a potential player in atherosclerosis [3,4] and cardiovascular diseases [5]. The gene discussed is LDLR; the disease is atherosclerosis.